- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.01. | FDA breakthrough status for Bluejay's CHD therapy brelovitug | ||
| 22.01. | Catalent backs decentralised manufacture of Galapagos' CAR-T therapy | ||
| 21.01. | NVIDIA champions Innophore partnership to model drug dynamics with AI | ||
| 21.01. | AI's potential in the women's health exciting, says Gates Foundation leader | ||
| 21.01. | Key Lead Generation Providers and Technology Solutions for the Pharmaceutical Industry | ||
| 21.01. | J&Js Lazcluze/Rybrevant combination obtains European approval to treat NSCLC | ||
| 21.01. | Junshi partners LEO Pharma for toripalimab distribution in Europe | ||
| 21.01. | Leading Sales Enablement, Prospecting and Automation Providers and Technology Solutions for the Pharmaceutical Industry | ||
| 21.01. | Active Pharmaceutical Ingredients and Intermediates for the Pharmaceutical Industry | ||
| 21.01. | CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial | ||
| 21.01. | Streamlining mesenchymal stem cell (MSC) expansion | ||
| 21.01. | Trump signs executive order to leave World Health Organization | ||
| 21.01. | FDA review designations: tracking 40 years of innovation | ||
| 21.01. | Health Canada gives Takeda's mCRC capsules market authorisation | ||
| 21.01. | EC approves GSK's Jemperli-chemo combo for endometrial cancer | ||
| 20.01. | $590m to Moderna from HHS for mRNA 'flu vax development | ||
| 20.01. | KeyMed partners with US-based biotech Prolium in bispecific antibody deal | ||
| 20.01. | FDA's START and CoGenT pilot programmes: Streamlining rare disease drug approvals | ||
| 20.01. | Interleukin inhibitors remain a strong growth driver in dermatology | ||
| 20.01. | Leading Account and Intent-Based Sales and Marketing Providers and Technology Solutions for the Pharmaceutical Industry | ||
| 20.01. | Arrowhead's plozasiran set for FDA review as Tryngolza challenge looms | ||
| 20.01. | AstraZeneca secures first BTK approval in first-line mantle cell lymphoma | ||
| 20.01. | Feinstein Institutes gains NIH grant to explore ghrelin for GI-ARS | ||
| 20.01. | Leading Sales and Marketing Intent Data, Database and Data Enrichment Providers and Technology Solutions for the Pharmaceutical Industry | ||
| 20.01. | FDA approves Amgen's combo therapy for colorectal cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
